The treatment of some neoplastic diseases in children with a new cytostatic drug: peptichemio. Investigations of a possible interference with lymphocyte blastogenesis and chromosomes.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008213:Lymphocyte Activation / Q000187:drug effects; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D009447:Neuroblastoma / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010455:Peptides / Q000627:therapeutic use*; D012509:Sarcoma / Q000188:drug therapy; D009396:Wilms Tumor / Q000188:drug therapy
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D010455:Peptides